Notify me when Mats Wahlstrom files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| TLSI | TriSalus Life Sciences, Inc. | Common Stock, $0.0001 par value | 6% | $15.1M | $966K | 2.99M | +6.81% | Mats Wahlstrom | Jul 31, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|